Covered recipient · General Payments record
KYLE VAN SCHWICKERATH
Podiatric Medicine & Surgery Service Providers Podiatrist Foot & Ankle Surgery
General Payments · PY2020–2024
$10,335.19
- Reported across 108 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,518.76 | 8 |
| Food and Beverage | $708.83 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| VILEX LLC | $1,742.76 | 12 |
| Amgen Inc. | $191.85 | 10 |
| DEXCOM, INC. | $40.97 | 2 |
| BioWound Solutions, Inc. | $39.66 | 2 |
| Novo Nordisk AS | $38.08 | 2 |
| MannKind Corporation | $31.39 | 1 |
| Lilly USA, LLC | $28.32 | 2 |
| ABBVIE INC. | $27.33 | 1 |
| Xeris Pharmaceuticals, Inc. | $21.98 | 1 |
| Verity Pharmaceuticals Inc. | $20.98 | 1 |
| IBSA Pharma Inc. | $15.16 | 1 |
| Paratek Pharmaceuticals, Inc. | $15.04 | 1 |
| IDORSIA PHARMACEUTICALS US INC | $14.07 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (37)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $27.33 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106046746 | CMS |
| Amgen Inc. | $19.24 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117377712 | CMS |
| Amgen Inc. | $23.11 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117377714 | CMS |
| Amgen Inc. | $19.54 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111701132 | CMS |
| Amgen Inc. | $21.73 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117377716 | CMS |
| Amgen Inc. | $5.46 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111701134 | CMS |
| Amgen Inc. | $24.32 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117377718 | CMS |
| Amgen Inc. | $27.74 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117377720 | CMS |
| Amgen Inc. | $15.54 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111701136 | CMS |
| Amgen Inc. | $6.06 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111701138 | CMS |
| Amgen Inc. | $29.11 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117377722 | CMS |
| BioWound Solutions, Inc. | $7.01 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118399562 | CMS |
| BioWound Solutions, Inc. | $32.65 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118399578 | CMS |
| Dexcom, Inc. | $27.18 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153315222 | CMS |
| Dexcom, Inc. | $13.79 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153315224 | CMS |
| IBSA Pharma Inc. | $15.16 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142975273 | CMS |
| IDORSIA PHARMACEUTICALS US INC | $14.07 | 03/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146774418 | CMS |
| Lilly USA, LLC | $13.82 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135142293 | CMS |
| Lilly USA, LLC | $14.50 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135143265 | CMS |
| Mannkind Corporation | $31.39 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145849331 | CMS |
| Novo Nordisk Inc | $19.94 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097040851 | CMS |
| Novo Nordisk Inc | $18.14 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097074861 | CMS |
| Paratek Pharmaceuticals, Inc. | $15.04 | 01/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113918058 | CMS |
| Verity Pharmaceuticals Inc. | $20.98 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1080604796 | CMS |
| VILEX LLC | $529.26 | 05/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154915061 | CMS |
| VILEX LLC | $266.90 | 05/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154915069 | CMS |
| VILEX LLC | $361.20 | 05/08/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154915803 | CMS |
| VILEX LLC | $22.50 | 05/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154915065 | CMS |
| VILEX LLC | $22.50 | 05/09/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154915127 | CMS |
| VILEX LLC | $51.00 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154915213 | CMS |
| VILEX LLC | $61.00 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154915257 | CMS |
| VILEX LLC | $22.50 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154915147 | CMS |
| VILEX LLC | $27.00 | 05/10/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154915171 | CMS |
| VILEX LLC | $51.00 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154915245 | CMS |
| VILEX LLC | $61.00 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154915251 | CMS |
| VILEX LLC | $266.90 | 05/11/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1154915193 | CMS |
| Xeris Pharmaceuticals, Inc. | $21.98 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144602111 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.